Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature

Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature

Bullous pemphigoid constitutes a rare dermatological immune-related adverse event of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors. Herein, we review all published cases of anti-PD-1/PD-L1 related bullous pemphigoid and discuss current knowledge on this con...

Full description

Bibliographic Details
Main Authors: Aikaterini Tsiogka, Johann W. Bauer, Aikaterini Patsatsi
Format: Article
Language:English
Published: Society for Publication of Acta Dermato-Venereologica 2021-01-01
Series:Acta Dermato-Venereologica
Subjects:
autoimmune bullous disorder
bullous pemphigoid
pd-1 inhibitor
pd-l1 inhibitor
checkpoint inhibitor
immune-related adverse event
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3740

Internet

https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3740

Similar Items